Obesity

all catalysts(0)

nothing on the calendar yet

News(10)

• STAT+: NIH plans to block international researchers on visas from accessing key funding avenue
  The NIH plans to close the door on one of the few pathways available to international students on visas to forge a career in biomedical research in the U.S.
  stat · 3d ago
• ‘Significant’ demand for Revolution drug; Intellia pinpoints liver toxicity culprit
  Early indicators from a compassionate use plan led analysts to hike projections for daraxonrasib. Elsewhere, Intellia believes it’s answered a key safety question and Arrowhead moved to catch a rival.
  biopharma_dive · 3d ago
• Novo Nordisk’s CFO on the oral Wegovy rollout and beyond
  Novo Nordisk CFO Karsten Munk Knudsen joins “The Top Line” to discuss oral Wegovy’s rollout, the company’s raised outlook, why he’s still optimistic about CagriSema and more.
  fiercebiotech · 3d ago
• STAT+: FDA approves Replimune melanoma drug previously rejected twice
  The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a tumultuous saga.
  stat · 4d ago
• STAT+: Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments
  The FDA approved a novel type of treatment for narcolepsy made by Takeda, backing a new drug class that scientists hope can be used to treat other conditions.
  stat · 5d ago
• STAT+: Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI
  Federal health officials invited tech companies and lobbyists to closed-door meetings as they to seek to boost adoption of clinical AI.
  stat · 5d ago
• STAT+: Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI
  Federal health officials invited tech companies and lobbyists to closed-door meetings as they seek to boost adoption of clinical AI.
  stat · 5d ago
• Erica Schwartz confirmed as CDC director, filling nearly yearlong vacancy
  Now confirmed, Erica Schwartz is the third CDC nominee since Trump took office for his second term.
  stat · 5d ago
• Lilly confident in slow and steady Foundayo launch, as ex-US sales shine
  Foundayo clocked $98 million in sales in Q2, the first quarter it was available, compared to Novo’s $355 million for the same sales period.
  biospace · 5d ago
• STAT+: Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety
  With a second delayed report of a child's death in China, criticism is rising of a looser form of clinical trial. One expert: what "bothers me is the lack of…
  stat · 5d ago